CN105362951A - Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition - Google Patents
Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition Download PDFInfo
- Publication number
- CN105362951A CN105362951A CN201510927007.2A CN201510927007A CN105362951A CN 105362951 A CN105362951 A CN 105362951A CN 201510927007 A CN201510927007 A CN 201510927007A CN 105362951 A CN105362951 A CN 105362951A
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- medicinal composition
- gout
- chinese medicinal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/57—Birds; Materials from birds, e.g. eggs, feathers, egg white, egg yolk or endothelium corneum gigeriae galli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/586—Turtles; Tortoises, e.g. terrapins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/32—Burseraceae (Frankincense family)
- A61K36/328—Commiphora, e.g. mecca myrrh or balm of Gilead
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/884—Alismataceae (Water-plantain family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8966—Fritillaria, e.g. checker lily or mission bells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9064—Amomum, e.g. round cardamom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicinal composition for treating gout and a preparation method of the traditional Chinese medicinal composition, and relates to the field of traditional Chinese medicine. The traditional Chinese medicinal composition for treating gout consists of the following components in parts by weight: 20-40 parts of polygonum cuspidatum, 2-7 parts of lygodium japonicum, 8-15 parts of lysimachia christinae hance, 8-15 parts of cortex phellodendri, 8-15 parts of mangnolia officinalis, 8-15 parts of black beans, 2-7 parts of poria cocos, 2-7 parts of fruit of Chinese magnoliavine, 2-7 parts of liquorice root, 2-7 parts of root of Chinese pulsatilla, 2-7 parts of magnolia obavata, 2-7 parts of curcuma zedoary, 2-7 parts of tortoise plastron, 2-7 parts of rhizoma alismatis, 8-15 parts of dried orange peel, 2-7 parts of endothelium corneum gigeriae galli, 2-7 parts of bulbus fritillariae cirrhosae, 2-7 parts of fructus amomi, 2-7 parts of dendrobium nobile, 2-7 parts of myrrh and 8-15 parts of caulis spatholobi. The traditional Chinese medicinal composition is prepared by drying and grinding the various raw materials and decocting the raw materials in water. The traditional Chinese medicinal composition for treating gout disclosed by the invention is simple in preparation process and significant in curative effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition.
Background technology
Gout is the crystal dependency arthrosis caused by monosodium urate salt (MSU) deposits, directly related with the hyperuricemia caused by purine metabolic disturbance and (or) underexcretion, refer in particular to acute characteristic arthritis and chronic gout stone disease.Along with the development of society, the quickening of rhythm of life, the increase of life stress, the change of dietary structure, patient with gout number is also in increase.Gout is more common in middle-aged male, and women only accounts for 5%, mainly postmenopausal women, and current gout has rejuvenation trend.The natural history of gout can be divided into the fourth phase, i.e. asymptomatic hyperuricemia phase, acute stage, intermission, chronic phase.The outbreak of gout brings considerable distress to patient.The Western medicine of general treatment gout has side effect more or less, and easily recurs, and gout is effected a radical cure.
Summary of the invention
For above-mentioned technical problem, the invention provides a kind of Chinese medicine composition for the treatment of gout and preparation method thereof.The Chinese medicine composition for the treatment of gout of the present invention is made up of the component of following weight portion: Rhizoma Polygoni Cuspidati 20 ~ 40 parts, Spora Lygodii 2 ~ 7 parts, Herba Lysimachiae 8 ~ 15 parts, Cortex Phellodendri 8 ~ 15 parts, Cortex Magnoliae Officinalis 8 ~ 15 parts, 8 ~ 15 parts, Semen sojae atricolor, 2 ~ 7 parts, Poria, Fructus Schisandrae Chinensis 2 ~ 7 parts, 2 ~ 7 parts, Radix Glycyrrhizae, the Radix Pulsatillae 2 ~ 7 parts, Cortex Magnoliae Officinalis 2 ~ 7 parts, Rhizoma Curcumae 2 ~ 7 parts, Carapax et Plastrum Testudinis 2 ~ 7 parts, Rhizoma Alismatis 2 ~ 7 parts, Pericarpium Citri Reticulatae 8 ~ 15 parts, Endothelium Corneum Gigeriae Galli 2 ~ 7 parts, Bulbus Fritillariae Cirrhosae 2 ~ 7 parts, Fructus Amomi 2 ~ 7 parts, Herba Dendrobii 2 ~ 7 parts, Myrrha 2 ~ 7 parts, Caulis Spatholobi 8 ~ 15 parts.
Further, the Chinese medicine composition for the treatment of gout of the present invention is made up of the component of following weight portion: Rhizoma Polygoni Cuspidati 25 ~ 35 parts, Spora Lygodii 4 ~ 6 parts, Herba Lysimachiae 9 ~ 12 parts, Cortex Phellodendri 9 ~ 12 parts, Cortex Magnoliae Officinalis 9 ~ 12 parts, 9 ~ 12 parts, Semen sojae atricolor, 4 ~ 6 parts, Poria, Fructus Schisandrae Chinensis 4 ~ 6 parts, 4 ~ 6 parts, Radix Glycyrrhizae, the Radix Pulsatillae 4 ~ 6 parts, Cortex Magnoliae Officinalis 4 ~ 6 parts, Rhizoma Curcumae 4 ~ 6 parts, Carapax et Plastrum Testudinis 4 ~ 6 parts, Rhizoma Alismatis 4 ~ 6 parts, Pericarpium Citri Reticulatae 9 ~ 12 parts, Endothelium Corneum Gigeriae Galli 4 ~ 6 parts, Bulbus Fritillariae Cirrhosae 4 ~ 6 parts, Fructus Amomi 4 ~ 6 parts, Herba Dendrobii 4 ~ 6 parts, Myrrha 4 ~ 6 parts, Caulis Spatholobi 9 ~ 12 parts.
Particularly, the Chinese medicine composition for the treatment of gout of the present invention is made up of the component of following weight portion: Rhizoma Polygoni Cuspidati 30 parts, Spora Lygodii 5 parts, Herba Lysimachiae 10 parts, Cortex Phellodendri 10 parts, Cortex Magnoliae Officinalis 10 parts, 10 parts, Semen sojae atricolor, 5 parts, Poria, Fructus Schisandrae Chinensis 5 parts, 5 parts, Radix Glycyrrhizae, the Radix Pulsatillae 5 parts, Cortex Magnoliae Officinalis 5 parts, Rhizoma Curcumae 5 parts, Carapax et Plastrum Testudinis 5 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 5 parts, Bulbus Fritillariae Cirrhosae 5 parts, Fructus Amomi 5 parts, Herba Dendrobii 5 parts, Myrrha 5 parts, Caulis Spatholobi 10 parts.
The preparation method of the Chinese medicine composition for the treatment of gout of the present invention is: by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 4 ~ 7 times of weight, decoct 40min ~ 2h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 4 ~ 7 times of weight, decoct 2h ~ 5h, discard insoluble matter, merge extractive liquid, to obtain final product.
Particularly, by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 6 times of weight, decoct 1h, extraction fluid and insoluble matter, add in the water of 5 times of weight again by insoluble matter, decoct 3h, discard insoluble matter, merge extractive liquid, to obtain final product.
In key component of the present invention:
Rhizoma Polygoni Cuspidati mildly bitter flavor, cold nature.Return liver, gallbladder, lung meridian.Dampness removing jaundice eliminating, heat-clearing and toxic substances removing, eliminating stasis to stop pain, relieving cough and resolving phlegm.For jaundice due to damp-heat, stranguria with turbid discharge, leukorrhagia, rheumatic arthralgia, carbuncle sore tumefacting virus, burn due to hot liquid or fire, amenorrhea, lump in the abdomen, instep plays damage, cough due to lung-heat.
Herba Lysimachiae sweet in the mouth, salty, cold nature.Return liver, gallbladder, kidney, urinary bladder channel.Dampness removing jaundice eliminating, inducing diuresis for treating stranguria syndrome, removing toxic substances and promoting subsidence of swelling.For jaundice due to damp-heat, gallbladder-distention hypochondriac pain, stranguria caused by urinary stone, pyretic stranguria, difficulty and pain in micturition, carbuncle furuncle, snake bite and insect sting.
Cortex Phellodendri bitter in the mouth, cold in nature.Return kidney, urinary bladder channel.Have heat clearing and damp drying, pathogenic fire purging removes steams, effect of detoxification sore treatment.For damp-heat dysentery, jaundice dark coloured urine, leukorrhagia pudendal pruritus, the puckery pain of pyretic stranguria, beriberi flaccidity is knitted, hectic fever due to YIN-deficiency consumptive fever, night sweat, seminal emission, sore swollen toxin, eczema eczema.Stir-baked CORTEX PHELLODENDRI with salt solution nourishing YIN to lower pathogenic fire.For hyperactivity of fire caused by deficiency of YIN, night sweat hectic fever due to YIN-deficiency.
Cortex Magnoliae Officinalis bitter in the mouth, pungent, warm in nature, return spleen, stomach, lung, large intestine channel.Dampness expectorant, the therapeutic method to keep the adverse QI flowing downwards is except full.For humidity hysteresis damaging the spleen and stomach, gastral cavity painful abdominal mass is vomited and diarrhoea, and stagnation of QI due to dyspepsia, abdominal distention constipation, phlegm retention is breathed with cough.
Caulis Spatholobi sweet in the mouth, hardship, warm in nature, return liver, kidney channel, blood circulation promoting and enriching, menstruction regulating and pain relieving, relaxing muscles and tendons and activating QI and blood in the collateral.For menoxenia, dysmenorrhea, amenorrhea, rheumatic arthralgia, paralysis and numbness, blood deficiency and yellow complexion.
Semen sojae atricolor sweet in the mouth, cold nature, property is put down, enter spleen, kidney channel.The kidney invigorating tonifying YIN, invigorating spleen to remove dampness, except thermal detoxification.
Pericarpium Citri Reticulatae: bitter in the mouth, pungent, warm in nature.Return lung, spleen channel.Regulating qi-flowing for strengthening spleen, drying dampness to eliminate phlegm.For distension and fullness in the abdomen, lack of appetite and vomiting, cough with copious phlegm.
The Chinese medicine composition for the treatment of gout of the present invention take Rhizoma Polygoni Cuspidati as monarch drug, Herba Lysimachiae, Cortex Phellodendri, Pericarpium Citri Reticulatae, Cortex Magnoliae Officinalis, Caulis Spatholobi, Semen sojae atricolor are ministerial drug, Spora Lygodii, Poria, Fructus Schisandrae Chinensis, the Radix Pulsatillae, Cortex Magnoliae Officinalis, Rhizoma Curcumae, Carapax et Plastrum Testudinis, Rhizoma Alismatis, Endothelium Corneum Gigeriae Galli, Bulbus Fritillariae Cirrhosae, Fructus Amomi, Herba Dendrobii, Myrrha are adjuvant drug, and Radix Glycyrrhizae is for making medicine.By scientific compatibility, each flavour of a drug synergism, full side has
rheumatism numbness bitterly, carbuncle sore tumefacting virus,heat-clearing and toxic substances removing, blood stasis dispelling damp eliminating, promoting blood circulation to remove obstruction in the collateral, the merit of reducing swelling and alleviating pain, can be used for treating the outbreak of various types of gout, and side effect is little.Preparation technology is simple, evident in efficacy.
In order to understand better and implement, the following detailed description of the present invention.
Detailed description of the invention
preparation embodiment 1
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, Rhizoma Polygoni Cuspidati 20 parts, Spora Lygodii 2 parts, Herba Lysimachiae 8 parts, Cortex Phellodendri 8 parts, Cortex Magnoliae Officinalis 8 parts, 8 parts, Semen sojae atricolor, 2 parts, Poria, Fructus Schisandrae Chinensis 2 parts, 2 parts, Radix Glycyrrhizae, the Radix Pulsatillae 2 parts, Cortex Magnoliae Officinalis 2 parts, Rhizoma Curcumae 2 parts, Carapax et Plastrum Testudinis 2 parts, Rhizoma Alismatis 2 parts, Pericarpium Citri Reticulatae 8 parts, Endothelium Corneum Gigeriae Galli 2 parts, Bulbus Fritillariae Cirrhosae 2 parts, Fructus Amomi 2 parts, Herba Dendrobii 2 parts, Myrrha 2 parts, Caulis Spatholobi 8 parts clean, dry pulverize after add in the water of 4 times of weight, decoct 40min, extraction fluid and insoluble matter, insoluble matter is added again in the water of 4 times of weight, decoct 2h, discard insoluble matter, merge extractive liquid, to obtain final product.
preparation embodiment 2
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, Rhizoma Polygoni Cuspidati 40 parts, Spora Lygodii 7 parts, Herba Lysimachiae 15 parts, Cortex Phellodendri 15 parts, Cortex Magnoliae Officinalis 15 parts, 15 parts, Semen sojae atricolor, 7 parts, Poria, Fructus Schisandrae Chinensis 7 parts, 7 parts, Radix Glycyrrhizae, the Radix Pulsatillae 7 parts, Cortex Magnoliae Officinalis 7 parts, Rhizoma Curcumae 7 parts, Carapax et Plastrum Testudinis 7 parts, Rhizoma Alismatis 7 parts, Pericarpium Citri Reticulatae 15 parts, Endothelium Corneum Gigeriae Galli 7 parts, Bulbus Fritillariae Cirrhosae 7 parts, Fructus Amomi 7 parts, Herba Dendrobii 7 parts, Myrrha 7 parts, Caulis Spatholobi 15 parts is cleaned, dry and add in the water of 7 times of weight after pulverizing, decoct 2h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 7 times of weight, decoct 5h, discard insoluble matter, merge extractive liquid, obtain.
preparation embodiment 3
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, by Rhizoma Polygoni Cuspidati 25 parts, Spora Lygodii 4 parts, Herba Lysimachiae 9 parts, Cortex Phellodendri 9 parts, Cortex Magnoliae Officinalis 9 parts, 9 parts, Semen sojae atricolor, 4 parts, Poria, Fructus Schisandrae Chinensis 4 parts, 4 parts, Radix Glycyrrhizae, the Radix Pulsatillae 4 parts, Cortex Magnoliae Officinalis 4 parts, Rhizoma Curcumae 4 parts, Carapax et Plastrum Testudinis 4 parts, Rhizoma Alismatis 4 parts, Pericarpium Citri Reticulatae 9 parts, Endothelium Corneum Gigeriae Galli 4 parts, Bulbus Fritillariae Cirrhosae 4 parts, Fructus Amomi 4 parts, Herba Dendrobii 4 parts, Myrrha 4 parts, Caulis Spatholobi 9 parts clean, dry pulverize after add in the water of 6 times of weight, decoct 1h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 6 times of weight, decoct 4h, discard insoluble matter, merge extractive liquid, to obtain final product.
preparation embodiment 4
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, by Rhizoma Polygoni Cuspidati 35 parts, Spora Lygodii 6 parts, Herba Lysimachiae 12 parts, Cortex Phellodendri 12 parts, Cortex Magnoliae Officinalis 12 parts, 12 parts, Semen sojae atricolor, 6 parts, Poria, Fructus Schisandrae Chinensis 6 parts, 6 parts, Radix Glycyrrhizae, the Radix Pulsatillae 6 parts, Cortex Magnoliae Officinalis 6 parts, Rhizoma Curcumae 6 parts, Carapax et Plastrum Testudinis 6 parts, Rhizoma Alismatis 6 parts, Pericarpium Citri Reticulatae 12 parts, Endothelium Corneum Gigeriae Galli 6 parts, Bulbus Fritillariae Cirrhosae 6 parts, Fructus Amomi 6 parts, Herba Dendrobii 6 parts, Myrrha 6 parts, Caulis Spatholobi 12 parts clean, dry pulverize after add in the water of 5 times of weight, decoct 1.5h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 5 times of weight, decoct
discard insoluble matter, merge extractive liquid, to obtain final product.
preparation embodiment 5
The Chinese medicine composition preparation method for the treatment of gout of the present invention is:
By weight, by Rhizoma Polygoni Cuspidati 30 parts, Spora Lygodii 5 parts, Herba Lysimachiae 10 parts, Cortex Phellodendri 10 parts, Cortex Magnoliae Officinalis 10 parts, 10 parts, Semen sojae atricolor, 5 parts, Poria, Fructus Schisandrae Chinensis 5 parts, 5 parts, Radix Glycyrrhizae, the Radix Pulsatillae 5 parts, Cortex Magnoliae Officinalis 5 parts, Rhizoma Curcumae 5 parts, Carapax et Plastrum Testudinis 5 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 5 parts, Bulbus Fritillariae Cirrhosae 5 parts, Fructus Amomi 5 parts, Herba Dendrobii 5 parts, Myrrha 5 parts, Caulis Spatholobi 10 parts is cleaned, dry and add in the water of 6 times of weight after pulverizing, decoct 1h, extraction fluid and insoluble matter, insoluble matter is added again in the water of 5 times of weight, decoct 3h, discard insoluble matter, merge extractive liquid, obtain.
case embodiment
1. week certain, man, 43 years old, gout history 5 years, clinical manifestation is Metatarsophalangeal joint red and swollen heat pain, joint joint stuffiness, starts the Chinese medicine composition taking the obtained treatment gout of the embodiment of the present invention 1 in May, 2014, every day 2 times, each 200ml, transference cure after 3 months, continues to take drug withdrawal after 3 months, so far without recurrence, whole drug administration process is without any side effects.
2. Zheng, female, 59 years old, gout history 1 year, clinical manifestation is finger thumb joint redness, and ancon is red and swollen, falls ill and within second day, starts to take the Chinese medicine composition of the obtained treatment gout of the embodiment of the present invention 2, every day 3 times, each 300ml, transference cure after 3 days, whole drug administration process is without any side effects.
3. Wei, man, 54 years old, gout history 7 years, clinical manifestation was big toe congestion and swelling pain outside right crus of diaphragm, the symptoms such as heating.Start the Chinese medicine composition taking the obtained treatment gout of the embodiment of the present invention 3 in November, 2011, every day 2 times, each 200ml, transference cure after April, continues to take drug withdrawal after 3 months, and so far without recurrence, whole drug administration process is without any side effects.
The present invention is not limited to above-mentioned embodiment, if do not depart from the spirit and scope of the present invention to various change of the present invention or distortion, if these are changed and distortion belongs within claim of the present invention and equivalent technologies scope, then the present invention is also intended to comprise these changes and distortion.
Claims (5)
1. treat a Chinese medicine composition for gout, it is characterized in that being made up of the component of following weight portion: Rhizoma Polygoni Cuspidati 20 ~ 40 parts, Spora Lygodii 2 ~ 7 parts, Herba Lysimachiae 8 ~ 15 parts, Cortex Phellodendri 8 ~ 15 parts, Cortex Magnoliae Officinalis 8 ~ 15 parts, 8 ~ 15 parts, Semen sojae atricolor, 2 ~ 7 parts, Poria, Fructus Schisandrae Chinensis 2 ~ 7 parts, 2 ~ 7 parts, Radix Glycyrrhizae, the Radix Pulsatillae 2 ~ 7 parts, Cortex Magnoliae Officinalis 2 ~ 7 parts, Rhizoma Curcumae 2 ~ 7 parts, Carapax et Plastrum Testudinis 2 ~ 7 parts, Rhizoma Alismatis 2 ~ 7 parts, Pericarpium Citri Reticulatae 8 ~ 15 parts, Endothelium Corneum Gigeriae Galli 2 ~ 7 parts, Bulbus Fritillariae Cirrhosae 2 ~ 7 parts, Fructus Amomi 2 ~ 7 parts, Herba Dendrobii 2 ~ 7 parts, Myrrha 2 ~ 7 parts, Caulis Spatholobi 8 ~ 15 parts.
2. the Chinese medicine composition for the treatment of gout according to claim 1, it is characterized in that being made up of the component of following weight portion: Rhizoma Polygoni Cuspidati 25 ~ 35 parts, Spora Lygodii 4 ~ 6 parts, Herba Lysimachiae 9 ~ 12 parts, Cortex Phellodendri 9 ~ 12 parts, Cortex Magnoliae Officinalis 9 ~ 12 parts, 9 ~ 12 parts, Semen sojae atricolor, 4 ~ 6 parts, Poria, Fructus Schisandrae Chinensis 4 ~ 6 parts, 4 ~ 6 parts, Radix Glycyrrhizae, the Radix Pulsatillae 4 ~ 6 parts, Cortex Magnoliae Officinalis 4 ~ 6 parts, Rhizoma Curcumae 4 ~ 6 parts, Carapax et Plastrum Testudinis 4 ~ 6 parts, Rhizoma Alismatis 4 ~ 6 parts, Pericarpium Citri Reticulatae 9 ~ 12 parts, Endothelium Corneum Gigeriae Galli 4 ~ 6 parts, Bulbus Fritillariae Cirrhosae 4 ~ 6 parts, Fructus Amomi 4 ~ 6 parts, Herba Dendrobii 4 ~ 6 parts, Myrrha 4 ~ 6 parts, Caulis Spatholobi 9 ~ 12 parts.
3. the Chinese medicine composition for the treatment of gout according to claim 2, is characterized in that being made up of the component of following weight portion: Rhizoma Polygoni Cuspidati 30 parts, Spora Lygodii 5 parts, Herba Lysimachiae 10 parts, Cortex Phellodendri 10 parts, Cortex Magnoliae Officinalis 10 parts, 10 parts, Semen sojae atricolor, 5 parts, Poria, Fructus Schisandrae Chinensis 5 parts, 5 parts, Radix Glycyrrhizae, the Radix Pulsatillae 5 parts, Cortex Magnoliae Officinalis 5 parts, Rhizoma Curcumae 5 parts, Carapax et Plastrum Testudinis 5 parts, Rhizoma Alismatis 5 parts, Pericarpium Citri Reticulatae 10 parts, Endothelium Corneum Gigeriae Galli 5 parts, Bulbus Fritillariae Cirrhosae 5 parts, Fructus Amomi 5 parts, Herba Dendrobii 5 parts, Myrrha 5 parts, Caulis Spatholobi 10 parts.
4. prepare the method for the Chinese medicine composition of the treatment gout described in claims 1 to 3 any one, it is characterized in that: by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 4 ~ 7 times of weight, decoct 40min ~ 2h, extraction fluid and insoluble matter, add in the water of 4 ~ 7 times of weight again by insoluble matter, decoct 2h ~ 5h, discard insoluble matter, merge extractive liquid, to obtain final product.
5. the preparation method of the Chinese medicine composition for the treatment of gout according to claim 4, it is characterized in that: by above-mentioned formula ratio, each raw material is cleaned, dry pulverizing after add in the water of 6 times of weight, decoct 1h, extraction fluid and insoluble matter, add in the water of 5 times of weight again by insoluble matter, decoct 3h, discard insoluble matter, merge extractive liquid, to obtain final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510927007.2A CN105362951A (en) | 2015-12-14 | 2015-12-14 | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510927007.2A CN105362951A (en) | 2015-12-14 | 2015-12-14 | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105362951A true CN105362951A (en) | 2016-03-02 |
Family
ID=55365904
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510927007.2A Pending CN105362951A (en) | 2015-12-14 | 2015-12-14 | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105362951A (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240378A (en) * | 2010-05-10 | 2011-11-16 | 张金荣 | Pharmaceutical composition for treating gout and preparation method thereof |
| CN103656509A (en) * | 2013-12-10 | 2014-03-26 | 赵财 | Traditional Chinese medicine formula for treating gout |
| CN104721645A (en) * | 2015-03-03 | 2015-06-24 | 刘正菊 | Traditional Chinese medicine composition for treating gout and preparation method of traditional Chinese medicine composition |
-
2015
- 2015-12-14 CN CN201510927007.2A patent/CN105362951A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240378A (en) * | 2010-05-10 | 2011-11-16 | 张金荣 | Pharmaceutical composition for treating gout and preparation method thereof |
| CN103656509A (en) * | 2013-12-10 | 2014-03-26 | 赵财 | Traditional Chinese medicine formula for treating gout |
| CN104721645A (en) * | 2015-03-03 | 2015-06-24 | 刘正菊 | Traditional Chinese medicine composition for treating gout and preparation method of traditional Chinese medicine composition |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105288518A (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
| CN103705809A (en) | Traditional Chinese medicine for curing gout | |
| CN104324259A (en) | Pharmaceutical composition for treating hepatitis B and preparation method of pharmaceutical composition | |
| CN103055266B (en) | Chinese medicinal herb composition for treating liver cancer and preparation method thereof | |
| CN103877286A (en) | Orally taken medicine for treating erysipelas and preparation method thereof | |
| CN103800693A (en) | Traditional Chinese medicine preparation for treating chronic pharyngitis | |
| CN103800697A (en) | Traditional Chinese medicine composition for treating pharyngitis | |
| CN101244183B (en) | Chinese medicine composing prescription for treating children's lymphoglandulae mesentericae intumesce | |
| CN105435100A (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
| CN104758676A (en) | Medicine for treating damp-heat in resistance-type epigastric pain | |
| CN104984204A (en) | Traditional Chinese medicine for treating ulcerative colitis | |
| CN104547941A (en) | Traditional Chinese medicine composition for preventing and treating cerebral thrombosis | |
| CN104758668A (en) | Traditional Chinese medicine composition for treating tympanites with syndrome of accumulation and binding of water-heat | |
| CN110193076A (en) | A kind of Chinese medicine composition and preparation for treating hypertension, hyperlipidemia, high blood viscosity | |
| CN105362951A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
| CN103520620B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of due to weakness of spleen and stomach chronic gastritis | |
| CN103520378B (en) | Chinese medicinal preparation for treating spleen-deficiency qi-stagnation type chronic gastritis and preparation method thereof | |
| CN105343802A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
| CN105343801A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
| CN105853933A (en) | Traditional Chinese medicine preparation for treating postoperative recurrence and metastasis of breast cancer and preparing method | |
| CN102580031B (en) | External Chinese medicament for treating chilblain and preparation method thereof | |
| CN105343799A (en) | Traditional Chinese medicinal composition for treating gout and preparation method of traditional Chinese medicinal composition | |
| CN105311586A (en) | Traditional Chinese medicine composition for treating gout and preparation method thereof | |
| CN106798849A (en) | It is a kind of to treat suppository drug of chronic prostatitis and preparation method thereof | |
| CN101623493A (en) | Herba artemisiae scopariae turtle shell soup for treating liver cirrhosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160302 |